Prepared by Dr. Raj Patel, FRM, Head of Quantitative Research | Reviewed by Priya Sharma, Lead Editor | Report ID: IGEMINI-2EB56D89-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns cash flow timeline a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 21.01x, 19% revenue expansion, and an RSI of 67 suggesting a neutral-bullish phase. We define critical support at $1969.2 and resistance at $2406.8.
Rating: Accumulate | Target Price: $2844.4 | Next Earnings: Jun 29
Download Full PDF Report
Price action carved a Inverse Head and Shoulders, confirmed by a 1.73x volume spike on May 07, 2026. The support at $2406.8 was tested.
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
RSI at 67 indicates a oversold state. Historical backtests suggest a +10.5% move within 10 sessions.
Relative to Healthcare peers, cash flow timeline sits at the 71th percentile in valuation, offering a potential value opportunity.
Free cash flow conversion remains robust at 92%, supporting the 2.11% dividend and buybacks.
Dark pool prints show a 29%% surge in block trades, indicating institutional accumulation before Jun 29 earnings.
Options skew is toward put at the 2209.88 strike, positioning for a directional move.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $2188 | $2078.6 |
| Market Cap | $20.68B | $16.54B |
| P/E Ratio | 21.01x | 17.9x |
| EPS (TTM) | $104.14 | $93.73 |
| Dividend Yield | 2.11% | 1.5% |
| Revenue Growth | 19% | 11.4% |
| Target Price | $2844.4 | - |
| Beta | 1.56 | 1.00 |